Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Obesity (Silver Spring) ; 30(9): 1806-1817, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-35918877

RESUMEN

OBJECTIVE: Physiological systems responsible for water homeostasis and energy metabolism are interconnected. This study hypothesized altered responses to dehydration including thirst, ad libitum water intake, and copeptin in men with obesity. METHODS: Forty-two men (22 lean and 20 with obesity) were stimulated by a 2-hour hypertonic saline infusion and a 24-hour water deprivation. In each dehydrating condition, thirst, ad libitum water intake after dehydration, and urinary and hormonal responses including copeptin were assessed. RESULTS: After each dehydration condition, ad libitum water intake was similar between both groups (p > 0.05); however, those with obesity reported feeling less thirsty (p < 0.05) and had decreased copeptin response and higher urinary sodium concentrations when stressed (p < 0.05). Angiotensin II, aldosterone, atrial and brain natriuretic peptides, and apelin concentrations did not differ by adiposity group and did not explain the different thirst or copeptin responses in men with obesity. However, leptin was associated with copeptin response in lean individuals during the hypertonic saline infusion (p < 0.05), but the relationship was diminished in those with obesity. CONCLUSIONS: Diminished thirst and copeptin responses are part of the obesity phenotype and may be influenced by leptin. Adiposity may impact pathways regulating thirst and vasopressin release, warranting further investigation.


Asunto(s)
Ingestión de Líquidos , Sed , Peso Corporal , Deshidratación , Ingestión de Líquidos/fisiología , Glicopéptidos , Humanos , Leptina , Masculino , Obesidad , Solución Salina Hipertónica/farmacología , Sed/fisiología
2.
Diabetologia ; 64(4): 914-922, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33404681

RESUMEN

AIMS/HYPOTHESIS: Impaired insulin clearance is implicated in the pathogenesis of type 2 diabetes, but prospective evidence remains limited. Therefore, we sought to identify factors associated with the metabolic clearance rate of insulin (MCRI) and to investigate whether lower MCRI is associated with increased risk of incident type 2 diabetes. METHODS: From a longitudinal cohort, 570 adult Native Americans without diabetes living in the Southwestern United States were characterised at baseline and 448 participants were monitored over a median follow-up period of 7.9 years with 146 (32%) incident cases of diabetes identified (fasting plasma glucose ≥7.0 mmol/l, 2 h plasma glucose [2-h PG] ≥11.1 mmol/l, or clinical diagnosis). At baseline, participants underwent dual-energy x-ray absorptiometry or hydrodensitometry to assess body composition, a 75 g OGTT, an IVGTT to assess acute insulin response (AIR), and a hyperinsulinaemic-euglycaemic clamp to assess MCRI and insulin action (M). RESULTS: In adjusted linear models, MCRI was inversely associated with body fat percentage (r = -0.35), fasting plasma insulin (r = -0.55) and AIR (r = -0.22), and positively associated with M (r = 0.17; all p < 0.0001). In multivariable Cox proportional hazard models, lower MCRI was associated with an increased risk of diabetes after adjustment for age, sex, heritage, body fat percentage, AIR, M, fasting plasma glucose, 2-h PG, and fasting plasma insulin (HR per one-SD difference in MCRI: 0.77; 95% CI 0.61, 0.98; p = 0.03). CONCLUSIONS/INTERPRETATION: Lower MCRI is associated with an unfavourable metabolic phenotype and is associated with incident type 2 diabetes independent of established risk factors. CLINICAL TRIAL REGISTRATION NUMBERS: ClinicalTrials.gov NCT00339482; NCT00340132.


Asunto(s)
Glucemia/metabolismo , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/etnología , Indígenas Norteamericanos , Insulina/sangre , Adulto , Arizona/epidemiología , Biomarcadores/sangre , Estudios Transversales , Diabetes Mellitus Tipo 2/diagnóstico , Femenino , Técnica de Clampeo de la Glucosa , Prueba de Tolerancia a la Glucosa , Humanos , Incidencia , Masculino , Tasa de Depuración Metabólica , Valor Predictivo de las Pruebas , Pronóstico , Estudios Prospectivos , Medición de Riesgo , Factores de Riesgo , Factores de Tiempo , Adulto Joven
3.
Otolaryngol Head Neck Surg ; 164(2): 229-233, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33045901

RESUMEN

Academic centers embody the ideals of otolaryngology and are the specialty's port of entry. Building a diverse otolaryngology workforce-one that mirrors society-is critical. Otolaryngology continues to have an underrepresentation of racial and ethnic minorities. The specialty must therefore redouble efforts, becoming more purposeful in mentoring, recruiting, and retaining underrepresented minorities. Many programs have never had residents who are Black, Indigenous, or people of color. Improving narrow, leaky, or absent pipelines is a moral imperative, both to mitigate health care disparities and to help build a more just health care system. Diversity supports the tripartite mission of patient care, education, and research. This commentary explores diversity in otolaryngology with attention to the salient role of academic medical centers. Leadership matters deeply in such efforts, from culture to finances. Improving outreach, taking a holistic approach to resident selection, and improving mentorship and sponsorship complement advances in racial disparities to foster diversity.


Asunto(s)
Centros Médicos Académicos , Educación de Postgrado en Medicina/organización & administración , Docentes Médicos/organización & administración , Internado y Residencia/métodos , Mentores , Otolaringología/educación , Procedimientos Quirúrgicos Otorrinolaringológicos/educación , Etnicidad , Humanos , Estados Unidos , Recursos Humanos
4.
S D Med ; 73(9): 404-409, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33260279

RESUMEN

INTRODUCTION: Venous thromboembolism (VTE) is a common cause of hospital morbidity and mortality. VTE risk assessment can provide a reduction in these events if optimal prophylactic interventions are taken. The Caprini Risk Assessment (CRA) score is a validated VTE risk scoring system available for hospitalized patient risk stratification. Implementation of risk assessment in an effective and systematic way could improve prevention of VTE events. METHODS: Patients were selected from a one-year retrospective chart review of adults in our hospital EMR who acquired a VTE during hospitalization. Periodic review of identified patients and determination of preventable causes of VTE were performed followed by application of the modified CRA scoring system at specific clinical event occurrences. Statistical analysis was performed via independent T-test of calculated CRA scores at the time of admission, VTE event, and discharge, comparing preventable and non-preventable groups. RESULTS: We identified 38 patients who acquired a VTE during hospitalization and 16 were determined to be preventable. A significant rise in CRA scores was observed from the time of admission, to the time of VTE, and at discharge. When comparing the preventable and non-preventable groups, there was no significant difference in CRA scores or trends. CONCLUSIONS: The CRA score is an important clinical tool that facilitates the optimal application of VTE prophylaxis. Our analysis emphasizes the importance of systematic VTE risk assessment and of improving the accuracy of the underlying clinical data. The study findings also suggest two higher risk groups that may benefit from more aggressive prophylaxis.


Asunto(s)
Tromboembolia Venosa , Adulto , Hospitales , Humanos , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Tromboembolia Venosa/epidemiología , Tromboembolia Venosa/prevención & control
5.
Mol Cell Biol ; 40(21)2020 10 13.
Artículo en Inglés | MEDLINE | ID: mdl-32868289

RESUMEN

The yeast prion [URE3] propagates as a misfolded amyloid form of the Ure2 protein. Propagation of amyloid-based yeast prions requires protein quality control (PQC) factors, and altering PQC abundance or activity can cure cells of prions. Yeast antiprion systems composed of PQC factors act at normal abundance to restrict establishment of the majority of prion variants that arise de novo While these systems are well described, how they or other PQC factors interact with prion proteins remains unclear. To gain insight into such interactions, we identified mutations outside the Ure2 prion-determining region that destabilize [URE3]. Despite residing in the functional domain, 16 of 17 mutants retained Ure2 activity. Four characterized mutations caused rapid loss of [URE3] yet allowed [URE3] to propagate under prion-selecting conditions. Two sensitized [URE3] to Btn2, Cur1, and Hsp42, but in different ways. Two others reduced amyloid formation in vitro Of these, one impaired prion replication and the other apparently impaired transmission. Thus, widely dispersed sites outside a prion's amyloid-forming region can contribute to prion character, and altering such sites can disrupt prion propagation by altering interactions with PQC factors.


Asunto(s)
Amiloide/metabolismo , Glutatión Peroxidasa/genética , Glutatión Peroxidasa/metabolismo , Mutación , Priones/genética , Priones/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/metabolismo , Sistemas de Transporte de Aminoácidos/genética , Sistemas de Transporte de Aminoácidos/metabolismo , Amiloide/genética , Proteínas de Choque Térmico/genética , Proteínas de Choque Térmico/metabolismo , Chaperonas Moleculares/genética , Chaperonas Moleculares/metabolismo , Saccharomyces cerevisiae/genética
6.
Diabetes Care ; 41(6): 1212-1217, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29622542

RESUMEN

OBJECTIVE: We compared the ability of 1- and 2-h plasma glucose concentrations (1h-PG and 2h-PG, respectively), derived from a 75-g oral glucose tolerance test (OGTT), to predict retinopathy. 1h-PG and 2h-PG concentrations, measured in a longitudinal study of an American Indian community in the southwestern U.S., a population at high risk for type 2 diabetes, were analyzed to assess the usefulness of the 1h-PG to identify risk of diabetic retinopathy (DR). RESEARCH DESIGN AND METHODS: Cross-sectional (n = 2,895) and longitudinal (n = 1,703) cohorts were assessed for the prevalence and incidence of DR, respectively, in relation to deciles of 1h-PG and 2h-PG concentrations. Areas under the receiver operating characteristic (ROC) curves for 1h-PG and 2h-PG were compared with regard to predicting DR, as assessed by direct ophthalmoscopy. RESULTS: Prevalence and incidence of DR, based on direct ophthalmoscopy, changed in a similar manner across the distributions of 1h-PG and 2h-PG concentrations. ROC analysis showed that 1h-PG and 2h-PG were of similar value in identifying prevalent and incident DR using direct ophthalmoscopy. 1h-PG cut points of 230 and 173 mg/dL were comparable to 2h-PG cut points of 200 mg/dL (type 2 diabetes) and 140 mg/dL (impaired glucose tolerance), respectively. CONCLUSIONS: 1h-PG is a useful predictor of retinopathy risk, has a predictive value similar to that of 2h-PG, and may be considered as an alternative glucose time point during an OGTT.


Asunto(s)
Glucemia/análisis , Diabetes Mellitus Tipo 2/sangre , Retinopatía Diabética/sangre , Retinopatía Diabética/diagnóstico , Intolerancia a la Glucosa/sangre , Indígenas Norteamericanos/estadística & datos numéricos , Adulto , Estudios Transversales , Diabetes Mellitus Tipo 2/epidemiología , Retinopatía Diabética/epidemiología , Técnicas de Diagnóstico Oftalmológico , Femenino , Intolerancia a la Glucosa/epidemiología , Prueba de Tolerancia a la Glucosa/estadística & datos numéricos , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Sudoeste de Estados Unidos/epidemiología , Factores de Tiempo , Adulto Joven
7.
Diabetologia ; 60(9): 1704-1711, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28664298

RESUMEN

AIMS/HYPOTHESIS: Elevated 2-h plasma glucose concentration (2 h-PG) during a 75 g OGTT predict the development of type 2 diabetes mellitus. However, 1-h plasma glucose concentration (1 h-PG) is associated with insulin secretion and may be a better predictor of type 2 diabetes. We aimed to investigate the association between 1 h-PG and 2 h-PG using gold standard methods for measuring insulin secretion and action. We also compared 1 h-PG and 2 h-PG as predictors of type 2 diabetes mellitus. METHODS: This analysis included adult volunteers without diabetes, predominantly Native Americans of Southwestern heritage, who were involved in a longitudinal epidemiological study from 1965 to 2007, with a baseline OGTT that included measurement of 1 h-PG. Group 1 (n = 716) underwent an IVGTT and hyperinsulinaemic-euglycaemic clamp for measurement of acute insulin response (AIR) and insulin-stimulated glucose disposal (M), respectively. Some members of Group 1 (n = 490 of 716) and members of a second, larger, group (Group 2; n = 1946) were followed-up to assess the development of type 2 diabetes (median 9.0 and 12.8 years follow-up, respectively). RESULTS: Compared with 2 h-PG (r = -0.281), 1 h-PG (r = -0.384) was more closely associated with AIR, whereas, compared with 1 h-PG (r = -0.340), 2 h-PG (r = -0.408) was more closely associated with M. Measures of 1 h-PG and 2 h-PG had similar abilities to predict type 2 diabetes, which did not change when both were included in the model. A 1 h-PG cut-off of 9.3 mmol/l provided similar levels of sensitivity and specificity as a 2 h-PG cut-off of 7.8 mmol/l; the latter is used to define impaired glucose tolerance, a recognised predictor of type 2 diabetes mellitus. CONCLUSIONS/INTERPRETATION: The 1 h-PG was associated with important physiological predictors of type 2 diabetes and was as effective as 2 h-PG for predicting type 2 diabetes mellitus. The 1 h-PG is, therefore, an alternative method of identifying individuals with an elevated risk of type 2 diabetes mellitus.


Asunto(s)
Diabetes Mellitus Tipo 2/sangre , Insulina/uso terapéutico , Glucemia/efectos de los fármacos , Técnica de Clampeo de la Glucosa , Prueba de Tolerancia a la Glucosa , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA